This inventor holds 1 USPTO granted patent. Top assignee: Gw Research Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Massimo Nabissi: Innovator in Cannabinoid Research
Introduction
Massimo Nabissi is a notable inventor based in Camerino, Italy. He has made significant contributions to the field of medical research, particularly in the use of cannabinoids for therapeutic purposes. His work focuses on innovative treatments for serious health conditions, showcasing his commitment to advancing medical science.
Latest Patents
Massimo Nabissi holds a patent for the "Use of cannabinoids in the treatment of multiple myeloma." This invention relates to the use of a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) in treating this aggressive form of cancer. The combination of THC and CBD has been found to be particularly effective in reducing cell viability and cell migration in multiple myeloma. The patent emphasizes the use of a highly purified extract, ensuring that cannabinoids are present at greater than 98% of the total extract. Alternatively, the cannabinoids may also be synthetically produced.
Career Highlights
Massimo Nabissi has established himself as a key figure in cannabinoid research. His innovative approach to utilizing cannabinoids in medical treatments has garnered attention in the scientific community. He is associated with Gw Research Limited, where he continues to explore the therapeutic potential of cannabinoids.
Collaborations
Massimo collaborates with various professionals in the field, including his coworker Colin Stott. Their combined expertise contributes to the advancement of cannabinoid research and its applications in medicine.
Conclusion
Massimo Nabissi's work in cannabinoid research represents a significant advancement in the treatment of multiple myeloma. His innovative patent highlights the potential of THC and CBD in medical applications, paving the way for future research and development in this area.